Brief: Mithra Sells Estetra, Neuralis, Specific Assets To Gedeon Richter for EUR 175 Mln
11/06/2024 17:58
June 11 (Reuters) - Mithra Pharmaceuticals SA
MITRA.BR :
* MITHRA PHARMACEUTICALS SELLS ESTETRA SRL, NEURALIS SA AND
SPECIFIC ASSETS TO GEDEON RICHTER
* MITHRA CDMO AND NOVALON SA REMAIN UNDER COURT PROTECTION
AND ARE
THEREFORE NOT AFFECTED BY TRANSACTION ANNOUNCED TODAY
* TRANSACTION AGGREGATE PRICE OF EUR 175 MILLION
Source text: tinyurl.com/yfwnyd3k
Further company coverage: MITRA.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Mithra Pharmaceuticals SA
See all newsBrief: Mithra Sells Estetra, Neuralis, Specific Assets To Gedeon Richter for EUR 175 Mln
Brief: Mithra Receives Additional EUR 2.5 Million To Advance Monetization
Brief: Mithra Secures Court Protection Measures To Advance Monetization Process
Brief: Mithra Pharmaceuticals Achieves LPR In Estetrol Skin Study
Brief: Mithra Applies To Liege Company Court For A "Transfer Under Judicial Supervision" For Mithra CDMO